CVS Health (CVS) needs to shed its image as a health care stock to move ahead, said TheStreet's Jim Cramer. The pharmacy and retailer is slated to report 2016 third-quarter results before Tuesday's opening bell. Wall Street is expecting earnings and revenue to rise year over year during the quarter. Analysts surveyed by FactSet are looking for adjusted earnings of $1.57 per share on revenue of $45.3 billion. During the same period in 2015, Woonsocket, R.I.-based CVS posted adjusted earnings of $1.28 per share on revenue of $38.6 billion. Additionally, CVS announced yesterday that it's planning to cut 600 corporate jobs in Rhode Island, Illinois and Arizona over the next two months.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.